| Bioactivity | 13,14-Dihydro PGE1 is a metabolite of PGE1 (Prostaglandin E1) which inhibits the ADP-induced platelet aggregation (ID50 = 10.8 ng/mL platelet rich plasma)[1]. |
| CAS | 19313-28-1 |
| Formula | C20H36O5 |
| Molar Mass | 356.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Katzenschlager R, et al. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation. Prostaglandins Leukot Essent Fatty Acids. 1992 Mar;45(3):207-10. |
13,14-Dihydro PGE1
CAS: 19313-28-1 F: C20H36O5 W: 356.50
13,14-Dihydro PGE1 is a metabolite of PGE1 (Prostaglandin E1) which inhibits the ADP-induced platelet aggregation (ID50
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.